News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
Burnett Patrick
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
08/22/2023 |
4
| Burnett Patrick (See Remarks) has filed a Form 4 on Arcutis Biotherapeutics, Inc.
Txns:
| Sold 300 shares
@ $7.05, valued at
$2.1k
Sold 1,305 shares
@ $7.04, valued at
$9.2k
|
|
03/08/2023 |
4
| Burnett Patrick (See Remarks) has filed a Form 4 on Arcutis Biotherapeutics, Inc.
Txns:
| Sold 851 shares
@ $15.2634, valued at
$13k
|
|
03/06/2023 |
4
| Burnett Patrick (See Remarks) has filed a Form 4 on Arcutis Biotherapeutics, Inc.
Txns:
| Sold 1,728 shares
@ $15.8178, valued at
$27.3k
Sold 23 shares
@ $16.52, valued at
$380 Granted 21,000 shares
@ $0 Granted 55,800 options to buy
@ $15.82, valued at
$882.8k
|
|
01/04/2023 |
4
| Burnett Patrick (See Remarks) has filed a Form 4 on Arcutis Biotherapeutics, Inc.
Txns:
| Sold 1,475 shares
@ $15.0075, valued at
$22.1k
|
|
03/07/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/04/2022 |
4
| Burnett Patrick (See Remarks) has filed a Form 4 on Arcutis Biotherapeutics, Inc.
Txns:
| Granted 16,750 shares
@ $0 |
|
03/05/2021 |
4
| Burnett Patrick (See Remarks) has filed a Form 4 on Arcutis Biotherapeutics, Inc.
Txns:
| Granted 9,500 shares
@ $0 Granted 28,800 options to buy
@ $32.44, valued at
$934.3k
|
|
08/05/2020 |
4
| Burnett Patrick (See Remarks) has filed a Form 4 on Arcutis Biotherapeutics, Inc.
Txns:
| Granted 33,500 shares
@ $0 Granted 320,000 options to buy
@ $25.89, valued at
$8.3M
|
|
08/05/2020 |
3
| Burnett Patrick (See Remarks) has filed a Form 3 on Arcutis Biotherapeutics, Inc. |
03/02/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/04/2019 |
4
| Burnett Patrick (Chief Medical Officer) has filed a Form 4 on Verrica Pharmaceuticals Inc.
Txns:
| Granted 52,508 options to buy
@ $11.32, valued at
$594.4k
|
|
06/14/2018 |
3
| Burnett Patrick (Chief Medical Officer) has filed a Form 3 on Verrica Pharmaceuticals Inc. |
|
|